Expert Review of Neurotherapeutics

(The median citation count of Expert Review of Neurotherapeutics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
Compassion focused therapy: a systematic review of its effectiveness and acceptability in clinical populations82
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease49
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system47
The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis47
Therapeutic advances in Dravet syndrome: a targeted literature review43
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives42
Mindfulness in migraine: A narrative review39
Update on diagnosis in disorders of consciousness33
Manganese-induced neurodegenerative diseases and possible therapeutic approaches31
Clinical diagnosis and management of small fiber neuropathy: an update on best practice31
The emerging role of psilocybin and MDMA in the treatment of mental illness29
Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice29
Diagnosing and managing post-stroke aphasia28
Noninvasive brain stimulation combined with exercise in chronic pain: a systematic review and meta-analysis26
A systematic review of morbidities suggestive of the multiple sclerosis prodrome26
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy26
The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders26
Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: a systematic review and suggestions for future research24
Nutrition-based interventions for mood disorders23
Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes22
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies22
Prevention of sudden unexpected death in epilepsy: current status and future perspectives22
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis22
Sex differences in schizophrenia relevant to clinical care22
Role of environmental factors in multiple sclerosis21
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults21
What is the potential of neurostimulation in the treatment of motor symptoms in schizophrenia?20
Clinical development of valbenazine for tics associated with Tourette syndrome20
Cannabis and multiple sclerosis20
Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review20
Gene therapy for Parkinson’s disease: contemporary practice and emerging concepts20
Focal cortical dysplasia: an update on diagnosis and treatment20
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome19
Emerging therapies in Friedreich’s Ataxia19
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs18
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management18
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease18
Motor imagery and gait control in Parkinson’s disease: techniques and new perspectives in neurorehabilitation17
Sensory stimulation programs in dementia: a systematic review of methods and effectiveness17
mHealth for pediatric chronic pain: state of the art and future directions17
Efficacy and safety of greater occipital nerve block for the treatment of cluster headache: a systematic review and meta-analysis17
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges17
Medication overuse headache: an overview of clinical aspects, mechanisms, and treatments16
Psychotherapy in recurrent depression: efficacy, pitfalls, and recommendations16
The therapeutic potential of galectin-1 and galectin-3 in the treatment of neurodegenerative diseases16
The effect of physical activity with and without cognitive demand on the improvement of executive functions and behavioral symptoms in children with ADHD16
Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms16
What is the potential of virtual reality for post-stroke sensorimotor rehabilitation?15
Combination therapy in migraine: asset or issue?15
Pain in cervical dystonia: mechanisms, assessment and treatment15
Current perspectives on galvanic vestibular stimulation in the treatment of Parkinson’s disease15
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone15
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies15
MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis15
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems15
Acute ischemic stroke management: concepts and controversies.A narrative review15
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia14
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group14
Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis14
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring14
Post-traumatic hydrocephalus: the Cinderella of Neurotrauma14
Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis13
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics13
The efficacy of executive function interventions in children with autism spectrum disorder: a systematic review and meta-analysis13
The evidence for multidisciplinary care in Parkinson’s disease13
What role should spinal cord MRI take in the future of multiple sclerosis surveillance?13
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis13
Real world considerations for newly approved CGRP receptor antagonists in migraine care12
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence12
Is it accurate to classify ALS as a neuromuscular disorder?12
Outcomes measures in idiopathic intracranial hypertension12
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice12
Metabolic treatments of migraine12
Speech and language therapy in primary progressive aphasia: a critical review of current practice12
The role of a potential biomarker in patients with migraine: review and new insights12
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?12
Evaluating and managing severe headache in the emergency department12
Current perspectives on exercise training in the management of multiple sclerosis11
Sydenham’s chorea: from pathophysiology to therapeutics11
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion11
Updated review on the link between cortical spreading depression and headache disorders11
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting11
Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options11
Can mindfulness-based interventions benefit people with dementia? Drawing on the evidence from a systematic review in populations with cognitive impairments11
Treatment of infantile spasms: why do we know so little?11
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders11
Managing bipolar disorder during pregnancy and the postpartum period: a critical review of current practice11
Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders11
Broad spectrum micronutrient formulas for the treatment of symptoms of depression, stress, and/or anxiety: a systematic review11
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation11
Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease10
The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials10
Should we move dementia research funding from a cure to its care?10
Status epilepticus in pregnancy: a literature review and a protocol proposal10
Considering patient age when treating multiple sclerosis across the adult lifespan10
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis10
Recent advancements in tension-type headache: a narrative review10
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis10
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome10
Current and emerging treatment modalities for spinocerebellar ataxias10
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy10
Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review9
Neurotechnologies as tools for cognitive rehabilitation in stroke patients9
Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approaches9
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry9
Memory deficits in patients with major depression: yes, they are trying hard enough!9
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis9
A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters9
Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management9
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis9
Current perspectives on sex differences in tension-type headache9
Reading mind from the eyes in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis9
Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress9
Emerging treatments for progressive myoclonus epilepsies9
Developments in treating the nonmotor symptoms of stroke9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures9
What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?9
A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders9
Incisionless MR-guided focused ultrasound: technical considerations and current therapeutic approaches in psychiatric disorders9
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials8
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia8
Multidisciplinary approach to degenerative cervical myelopathy8
Current perspectives on co-morbid depression and multiple sclerosis8
Deep brain stimulation for treatment-resistant depression: a safe and effective option8
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes8
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients8
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation8
Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review8
Autologous hematopoietic stem-cell transplantation in neurological disorders: current approach and future directions7
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment7
Moving beyond anti-aquaporin-4 antibodies: emerging biomarkers in the spectrum of neuromyelitis optica7
Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries7
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?7
Aripiprazole for the treatment of Tourette syndrome7
A reappraisal of the value of video-EEG recording in the emergency department7
Meniere disease subtyping: the direction of diagnosis and treatment in the future7
Diagnostic challenges in metabolic myopathies7
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review7
Recently available and emerging therapeutic strategies for the acute and prophylactic management of cluster headache: a systematic review and expert opinion7
Randomized controlled trial validating the use of perispinal etanercept to reduce post-stroke disability has wide-ranging implications7
‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine7
Suicidality and antiepileptic drugs in people with epilepsy: an update6
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease6
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance6
Considering hearing loss as a modifiable risk factor for dementia6
A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodes6
Updated perspectives on awake neurosurgery with cognitive and emotional assessment for patients with low-grade gliomas6
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine6
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper6
A review of magnetoencephalography use in pediatric epilepsy: an update on best practice6
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?6
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice6
Gene therapy and immunotherapy as promising strategies to combat Huntington’s disease-associated neurodegeneration: emphasis on recent updates and future perspectives6
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia6
Non-pharmacological treatments for pediatric refractory epilepsies6
Deep transcranial magnetic stimulation for obsessive compulsive disorder6
The severity of obsessive-compulsive symptoms in Tourette syndrome and its relationship with premonitory urges: a meta-analysis6
Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges6
Lasmiditan: an additional therapeutic option for the acute treatment of migraine6
Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry6
Hormonal therapies in migraine management: current perspectives on patient selection and risk management6
Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis6
Exercise is medicine: a new perspective for health promotion in bipolar disorder6
Developments in the mechanistic understanding and clinical application of deep brain stimulation for Parkinson’s disease5
Cinnarizine as an alternative recommendation for migraine prophylaxis: a narrative review5
Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis5
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry5
A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavio5
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy5
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports5
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugs5
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis5
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy5
Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes5
Gene and cell therapy and nanomedicine for the treatment of multiple sclerosis: bibliometric analysis and systematic review of clinical outcomes5
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review5
Narrative review of the multisensory integration tasks used with older adults: inclusion of multisensory integration tasks into neuropsychological assessment5
Emerging cytoprotective peptide therapies for stroke5
Exploring treatments for drooling in children with neurological disorders5
Novel therapeutic options for Dravet and Lennox-Gastaut syndrome5
The effect of transcranial magnetic stimulation on the recovery of attention and memory impairment following stroke: a systematic review and meta-analysis5
Tumefactive demyelination: updated perspectives on diagnosis and management5
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development5
Neuropsychological performance across symptom dimensions of obsessive-compulsive disorder: a comment on the state and critical review of the literature5
Improving long-term survival in diffuse intrinsic pontine glioma5
Dyspnea in Parkinson’s disease: an approach to diagnosis and management5
An update on acute and preventive treatments for migraine in children and adolescents5
Acute symptomatic neonatal seizures, brain injury, and long-term outcome: The role of neuroprotective strategies5
Smoking and disability progression in multiple sclerosis5
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment5
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis5
Efficacy and safety of greater occipital nerve block for the treatment of cervicogenic headache: a systematic review5
Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts5
Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapies5
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury4
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression4
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis4
The efficacy of rehabilitation in people with Guillain-Barrè syndrome: a systematic review of randomized controlled trials4
Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations4
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives4
Withdrawal seizures: possible risk factors4
Considerations when treating high-grade pediatric glioma patients with immunotherapy4
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper4
Treatment considerations in myasthenia gravis for the pregnant patient4
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication4
Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies4
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review4
Treating hallucinations in Parkinson’s disease4
Polyamines serum levels in episodic and chronic migraine4
Telerehabilitation in neurorehabilitation: has it passed the COVID test?4
Considering safety and patient tolerance in the use of ketogenic diet in the management of refractory and super-refractory status epilepticus: a systematic review4
Overcoming clinical challenges of refractory neuropathic pain4
Objective measurement versus clinician-based assessment for Parkinson’s disease4
Do we need to reconsider the classification of vestibular migraine?4
Drug profile: galcanezumab for prevention of cluster headache4
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts4
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant4
Postoperative pain: a review of emerging therapeutic options4
Emerging evidence for noninvasive vagus nerve stimulation for the treatment of vestibular migraine4
Developing precision treatments for epilepsy using patient and animal models4